Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Cardiovascular Research|May 26, 2004
Transcriptional regulation of FGF-2 gene expression in cardiac myocytesSarah K Jimenez, Farah Sheikh, Yan Jin, et al.Heart Failure Reviews|May 23, 2007
Fibroblast growth factor-2 and cardioprotectionElissavet Kardami, Karen Detillieux, Xin Ma, et al.Cardiovascular Research|July 28, 2004
Fibroblast growth factor 2 isoforms and cardiac hypertrophyElissavet Kardami, Zhi-Sheng Jiang, Sarah K Jimenez, et al.Cell Communication & Adhesion|October 17, 2008
Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblastsYan Zhang, Evelyn M Kanter, James G Laing, et al.Cardiovascular Research|March 22, 2014
The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependentWattamon Srisakuldee, Zhanna Makazan, Barbara E Nickel, et al.Molecular and Cellular Biochemistry|March 17, 2006
High glucose protects embryonic cardiac cells against simulated ischemiaVassiliki Malliopoulou, Christodoulos Xinaris, Iordanis Mourouzis, et al.Journal of Cell Science|January 2, 2004
Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytesBradley W Doble, Xitong Dang, Peipei Ping, et al.Journal of Molecular and Cellular Cardiology|October 19, 2006
High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1Zhi-Sheng Jiang, Madhumathy Jeyaraman, Ge-Bo Wen, et al.Journal of Molecular Endocrinology|June 4, 2024
Increased capacity to maintain glucose homeostasis in a transgenic mouse expressing human but not mouse growth hormone with developing high-fat diet-related insulin resistance, hepatic steatosis and adipose dysfunctionYan Jin, Jessica S Jarmasz, Shakila Sultana, et al.Oncotarget|November 21, 2017
Fibroblast growth factor-2-mediated protection of cardiomyocytes from the toxic effects of doxorubicin requires the mTOR/Nrf-2/HO-1 pathwayNavid Koleini, Barbara E Nickel, Jie Wang, et al.Pageof 6